Metagenomic, metabolomic, and lipidomic shifts associated with fecal microbiota transplantation for recurrent Clostridioides difficile infection
mSphere · 29.10.2024 · 9 (10)
DOI: 10.1128/msphere.00706-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSphere, erschienen am 29.10.2024. Verfasst von Arthur S McMillan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Genetics Program, Department of Biological Sciences, College of Science, North Carolina State University, Raleigh, North Carolina, USA. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Clostridium Infections, Clostridioides difficile, Metabolomics. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIDDK NIH HHS, NIEHS NIH HHS.
Abstract (Originalsprache)
Recurrent C. difficile infection (rCDI) is an urgent public health threat, for which the last resort and lifesaving treatment is a fecal microbiota transplant (FMT). However, the exact mechanisms that mediate a successful FMT are not well-understood. Here, we use longitudinal stool samples collected from patients undergoing FMT to evaluate intra-individual changes in the microbiome, metabolome, and lipidome after successful FMTs relative to their baselines pre-FMT. We show changes in the abundance of many lipids, specifically a decrease in acylcarnitines post-FMT, and a shift from conjugated bile acids pre-FMT to deconjugated secondary bile acids post-FMT. These changes correlate with a decrease in Enterobacteriaceae, which encode carnitine metabolism genes, and an increase in Lachnospiraceae, which encode bile acid altering genes such as bile salt hydrolases (BSHs) and the bile acid-inducible ( bai ) operon, post-FMT. We also show changes in gut microbe-encoded amino acid biosynthesis genes, of which Enterobacteriaceae was the primary contributor to amino acids C. difficile is auxotrophic for. Liquid chromatography, ion mobility spectrometry, and mass spectrometry (LC-IMS-MS) revealed a shift from microbial conjugation of primary bile acids pre-FMT to secondary bile acids post-FMT. Here, we define the structural and functional changes associated with a successful FMT and generate hypotheses that require further experimental validation. This information is meant to help guide the development of new microbiota-focused therapeutics to treat rCDI. IMPORTANCE Recurrent C. difficile infection is an urgent public health threat, for which the last resort and lifesaving treatment is a fecal microbiota transplant. However, the exact mechanisms that mediate a successful FMT are not well-understood. Here, we show changes in the abundance of many lipids, specifically acylcarnitines and bile acids, in response to FMT. These changes correlate with Enterobacteriaceae pre-FMT, which encodes carnitine metabolism genes, and Lachnospiraceae post-FMT, which encodes bile salt hydrolases and baiA genes. There was also a shift from microbial conjugation of primary bile acids pre-FMT to secondary bile acids post-FMT. Here, we define the structural and functional changes associated with a successful FMT, which we hope will help aid in the development of new microbiota-focused therapeutics to treat rCDI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetics Program, Department of Biological Sciences, College of Science, North Carolina State University, Raleigh, North Carolina, USA.
- Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
- Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Rex Digestive Healthcare, Raleigh, North Carolina, USA.
- Department of Pediatrics, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
ORCID-Profile: Arthur S McMillan, Erin S Baker, Casey M Theriot
Förderung
- NIGMS NIH HHS
- NIDDK NIH HHS
- NIEHS NIH HHS
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
- HHS | NIH | National Institute of Environmental Health Sciences
- HHS | NIH | National Institute of General Medical Sciences
- Environmental Protection Agency
Zitieren
APA
McMillan, A. S., Zhang, G., Dougherty, M. K., McGill, S. K., Gulati, A. S., Baker, E. S., & Theriot, C. M. (2024). Metagenomic, metabolomic, and lipidomic shifts associated with fecal microbiota transplantation for recurrent Clostridioides difficile infection. mSphere, 9(10). https://doi.org/10.1128/msphere.00706-24
Vancouver
McMillan AS, Zhang G, Dougherty MK, McGill SK, Gulati AS, Baker ES, et al. Metagenomic, metabolomic, and lipidomic shifts associated with fecal microbiota transplantation for recurrent Clostridioides difficile infection. mSphere. 2024;9(10). doi:10.1128/msphere.00706-24
BibTeX
@article{McMillan2024,
author = {McMillan, Arthur S and Zhang, Guozhi and Dougherty, Michael K and McGill, Sarah K and Gulati, Ajay S and Baker, Erin S and Theriot, Casey M},
title = {Metagenomic, metabolomic, and lipidomic shifts associated with fecal microbiota transplantation for recurrent Clostridioides difficile infection},
journal = {mSphere},
year = {2024},
volume = {9},
number = {10},
doi = {10.1128/msphere.00706-24}
}
EUVIMED